The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-(benzo[d]thiazol-2-yl)-N-(4-(2-(2-hydroxy-2-(pyridin-3-yl)ethylamino)ethyl)phenyl)benzamide ID: ALA1083831
PubChem CID: 46881937
Max Phase: Preclinical
Molecular Formula: C29H26N4O2S
Molecular Weight: 494.62
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1-c1nc2ccccc2s1
Standard InChI: InChI=1S/C29H26N4O2S/c34-26(21-6-5-16-30-18-21)19-31-17-15-20-11-13-22(14-12-20)32-28(35)23-7-1-2-8-24(23)29-33-25-9-3-4-10-27(25)36-29/h1-14,16,18,26,31,34H,15,17,19H2,(H,32,35)/t26-/m0/s1
Standard InChI Key: KYJMGBRNBMEYEY-SANMLTNESA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
-4.1639 -8.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1651 -9.0232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4503 -9.4360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7338 -9.0227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7367 -8.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4521 -7.7830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0238 -7.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3078 -8.1868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0269 -6.9520 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5948 -7.7716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1212 -8.1814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8341 -7.7662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5501 -8.1760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5503 -9.0011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2655 -9.4108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9794 -8.9956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9736 -8.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2579 -7.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6960 -9.4044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4083 -8.9883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4041 -8.1633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1249 -9.3971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1264 -10.2219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8421 -10.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5555 -10.2145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5486 -9.3853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8323 -8.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8249 -8.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4836 -7.6661 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.1489 -7.6781 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3967 -6.8912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2194 -6.8873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6255 -6.1739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2101 -5.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3842 -5.4720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9818 -6.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17 18 2 0
18 13 1 0
7 9 1 1
16 19 1 0
4 5 1 0
19 20 1 0
8 10 1 0
20 21 2 0
2 3 1 0
20 22 1 0
10 11 1 0
22 23 2 0
5 6 2 0
23 24 1 0
11 12 1 0
24 25 2 0
6 1 1 0
25 26 1 0
12 13 1 0
26 27 2 0
27 22 1 0
1 2 2 0
27 28 1 0
28 29 1 0
13 14 2 0
5 7 1 0
29 32 1 0
31 30 1 0
30 28 2 0
14 15 1 0
3 4 2 0
31 32 2 0
15 16 2 0
32 33 1 0
7 8 1 0
33 34 2 0
16 17 1 0
34 35 1 0
35 36 2 0
36 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 494.62Molecular Weight (Monoisotopic): 494.1776AlogP: 5.48#Rotatable Bonds: 9Polar Surface Area: 87.14Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.85CX Basic pKa: 9.45CX LogP: 4.95CX LogD: 2.92Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.24Np Likeness Score: -1.47
References 1. Goble SD, Wang L, Howell KL, Bansal A, Berger R, Brockunier L, DiSalvo J, Feighner S, Harper B, He J, Hurley A, Hreniuk D, Parmee E, Robbins M, Salituro G, Sanfiz A, Streckfuss E, Watkins E, Weber AE, Struthers M, Edmondson SD.. (2010) Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles., 20 (6): [PMID:20181479 ] [10.1016/j.bmcl.2010.01.130 ]